Using an ultra-high-throughput screen, our group identified two KLF5-selective compounds, CID 439501 and 5951923, that significantly decrease endogenous KLF5 protein levels and reduce the viability of several CRC cell lines [191]. The gene discussed is KLF5; the disease is colorectal carcinoma.